Anterior gradient 2 overexpression in lung adenocarcinoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 20, Issue 1, 2012, Pages 31-36

  Pizzi, Marco ^a   Fassan, Matteo ^a,b   Balistreri, Mariangela ^a   Galligioni, Alessandra ^a   Rea, Federico ^c   Rugge, Massimo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Departments of 0Ncology and Surgical Sciences   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

AGR2; immunohistochemistry; lung cancer; NSCLC

Indexed keywords

ANTERIOR GRADIENT 2 PROTEIN; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURGERY; CLINICAL ASSESSMENT; CONTROLLED STUDY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 83655167340     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3182233f9f     Document Type: Article

References (41)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics 2010. CA Cancer J Clin. 2010;60:277-300.
2. Parkin DM, Whelan SL, Ferlay J, et al. Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155. Lyon: IARC Press; 2002.
3. Shields PG. Molecular epidemiology of smoking and lung cancer. Oncogene. 2002;21:6870-6876. (Pubitemid 35221933)
4. Rivera MP, Metha AC. American College of Chest Physicians. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;3:131S-148S. (Pubitemid 47502804)
5. Loo PS, Thomas SC, Nicolson MC, et al. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol. 2010;5:442-447.
6. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005; 353:123-132. (Pubitemid 41058344)
7. Fassan M, Rea F, Pizzi M, et al. HER-2/neu expression is consistent in primary and metastatic lung adenocarcinoma. Lung Cancer. 2011; 71:371-372.
8. Kuyama S, Hotta K, Tabata M, et al. Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2008;3:477-482. (Pubitemid 351630274)
9. Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol. 2011;35:15-25.
10. Terry J, Leung S, Laskin J, et al. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol. 2010;34:1805-1811.
11. Fassina A, Corradin M, Zardo D, et al. Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules. Cytopathology. 2010. (In press).
12. Aberger F, Weidinger G, Grunz H, et al. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech Dev. 1998;72:115-130. (Pubitemid 28186711)
13. Brychtova V, Vojtesek B, Hrstka R. Anterior gradient 2: a novel player in tumor cell biology. Cancer Lett. 2011;304:1-7.
14. Wang Z, Hao Y, Lowe AW. The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res. 2008;68:492-497. (Pubitemid 351380076)
15. Park K, Chung YJ, So H, et al. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med. 2011. (In press).
16. Maresh EL, Mah V, Alavi M, et al. Differential expression of anterior gradient gene AGR2 in prostate cancer. BMC Cancer. 2010. (In press).
17. Vanderlaag KE, Hudak S, Bald L, et al. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin. Breast Cancer Res. 2010;12:R32.
18. Vivekanandan P, Micchelli ST, TorbensonM. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum Pathol. 2009;40: 293-299.
19. Fritzsche FR, Dahl E, Burkhardt M, et al. Expression of AGR2 in non small cell lung cancer. Histol Histopathol. 2007;22:703-708. (Pubitemid 47034136)
20. Rhodes DR, Yu J, Shanker K, et al. Oncomine: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6:1-6. (Pubitemid 38391943)
21. Rhodes DR, Yu J, Shanker K, et al. Large-scale metaanalysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. PNAS 2004;101: 9309-9314. (Pubitemid 38812872)
22. Xin W, Rhodes DR, Ingold C, et al. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol. 2003;162:255-261. (Pubitemid 36042007)
23. Travis WD, Brambilla E, Muller-Hermelink HK, et al, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon- France: IARC; 2004.
24. Fassan M, Rea F, Clemente R, et al. Somatostatin receptor type 2 (SSTR2) in bronchopulmonary carcinoids. Endocr Pathol. 2010;21: 204-205.
25. Rugge M, Fassan M, Clemente R, et al. Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients. Clin Cancer Res. 2008;14:149-154. (Pubitemid 351377990)
26. Riener MO, Pilarsky C, Gerhardt J, et al. Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma. Histol Histopathol. 2009;24:1121-1128.
27. Baffa R, Fassan M, Volinia S, et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol. 2009;219:214-221.
28. Fassan M, Volinia S, Palatini J, et al. MicroRNA expression profiling in human Barretts carcinogenesis. Int J Cancer. 2010. (In press).
29. Su LJ, Chang CW, Wu YC, et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics. 2007;8:140.
30. Stearman RS, Dwyer-Nield L, Zerbe L, et al. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol. 2005;167:1763-1775. (Pubitemid 41713326)
31. Landi MT, Dracheva T, Rotunno M, et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS ONE. 2008;3:e1651.
32. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. PNAS. 2001;98:13790-13795. (Pubitemid 33115977)
33. Su AI, Welsh JB, Sapinoso LM, et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res. 2001;61:7388-7393. (Pubitemid 32995021)
34. Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. PNAS. 2001;98: 13784-13789. (Pubitemid 33115976)
35. Lee ES, Son DS, Kim SH, et al. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res. 2008;14:7397-7404.
36. Bild AH, Yao G, Chang JT, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006;439: 353-357. (Pubitemid 43128862)
37. Rohrbeck A, Neukirchen J, Rosskopf M, et al. Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers. J Transl Med. 2008;6:69.
38. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
39. Zweitzig DR, Smirnov DA, Connelly MC, et al. Physiological stress induces the metastasis marker AGR2 in breast cancer cells. Mol Cell Biochem. 2007;306: 255-260. (Pubitemid 350001838)
40. Turano C, Coppari S, Altieri F, et al. Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol. 2002; 193:154-163.
41. Zhu H, Lam DC, Han KC, et al. High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines. Cancer Lett. 2007;245:303-314. (Pubitemid 44959355)